BMC Cancer

official impact factor 3.15
Search for
Advanced search
BMC Cancer
Tools
Share this article
Open Access Highly Access Email this article to a friend

Sunitinib treatment for patients with clear-cell metastatic renal cell carcinoma: clinical outcomes and plasma angiogenesis markers

Loukas F Kontovinis, Konstantinos T Papazisis*, Panagiota Touplikioti, Charalambos Andreadis, Despoina Mouratidou and Alexandros H Kortsaris

BMC Cancer 2009, 9:82 doi:10.1186/1471-2407-9-82

Fields marked * are required


Multiple email addresses should be separated with commas or semicolons.